COVID-19：エジプト､ファビピラビルを製造へ：EVA 社（動画）：
EVA Pharma to Start Manufacturing Antiviral Drug Favipiravir：
EVA Pharma开始生产抗病毒药物Favipiravir
COVID-19：
EVA Pharma：
Eva Pharmaは、カイロで事業展開する大手国際製薬会社です。
このたび抗ウイルス有効成分「ファビピラビル」新薬の製造を、開始すると発表しました。
「ファビピラビル」：
ロシアでの患者治療で、有効であることが証明されています。
この治療法は現在、日本を含むロシア以外のいくつかの国でテストされています。
Dr. Riyad Armanius,
Managing Director of Eva Pharma , said
that his company has already started manufacturing the drug within it’s factories, and has already started producing samples,
explaining that there is coordination between Eva and the medical authorities in Egypt to approve that the drug is safe to use in the treatment of patients with the emerging coronavirus during the upcoming period.
Earlier this month, Eva Pharma
announced it had reached a “historic” deal with Gilead Sciences Inc to become the licensed manufacturer of the US company’s antiviral treatment Remdesivir for coronavirus in 127 countries.
Sada El balad
https://see.news/eva-pharma-to-start-manufacturing-antiviral-drug-favipiravir/